The Synthetic Standard
Tuesday, June 17th, 2025
Daily Artificial Intelligence
Loading...

More

Yankees Place Aaron Judge on 10-Day IL with Toe Injury 2:11AM
PGA Tour Announces Shock Reconciliation with Saudi-Backed LIV Golf and DP World Tour 2:08AM
Top Stories This Week in Essex County: From Caldwells to Montclair 6:13PM
Debt Ceiling Talks Hit a Snag, Negotiations Paused Between White House and House Republicans 3:57PM
Blue Origin Wins NASA Contract to Develop Crewed Lunar Lander for Artemis Program 2:40PM
D.C. Police Lieutenant Indicted for Obstruction and Making False Statements in Connection with Proud Boys Leader 1:58PM
Denver Business Journal Announces Small Business Awards Finalists and Winner 1:31PM
Tesco Chairman John Allan Resigns Amid Allegations of Inappropriate Behaviour 1:16PM
Morgan Stanley CEO James Gorman to Step Down, Succession Race Begins 12:42PM
Foot Locker Shares Plummet 25% as Company Cuts Annual Forecasts 11:47AM
The Synthetic Standard
Stay up to date with the latest stories

Get a daily newsletter delivered straight to your inbox with the top stories of the day.

Publication

  • About
  • Staff
  • Archive
  • Contact

Legal

  • Privacy Policy
  • Terms & Conditions

The content on this site was not created under human supervision. No warranty, express or implied, is made as to the truth, accuracy, or completeness of the information provided. Readers are advised to verify any information independently before relying on it.

© 2025 The Synthetic Standard. All Rights Reserved.

Twitter page
April 14, 2023

Justice Department Seeks Nationwide Mail Ban on Abortion Medication Mifepristone

Justice Department Seeks Nationwide Mail Ban on Abortion Medication Mifepristone
Alexander Whitford
Alexander Whitford

The Justice Department has asked the Supreme Court to enforce a nationwide mail ban on mail prescriptions of abortion medication mifepristone. This ruling would apply even in pro-choice states like New York, and it is up to Justice Samuel Alito to decide by 1 a.m. Saturday whether or not to impose severe restrictions on the widely-used pill.

This legal battle over mifepristone comes less than a year after conservative justices reversed Roe v. Wade, allowing more than a dozen Republican-run states to effectively ban abortion outright. The FDA argues that the appeals panel does not go far enough in protecting Americans' access to safe and effective reproductive care while awaiting final court rulings.

Both the White House and Danco Laboratories, which manufactures Mifeprex brand pills used for medical abortions, have urged the U.S Supreme Court to block lower court rulings barring access to this drug due its potential "regulatory chaos." They argue that such decisions may result in inaccurate labeling for mifepristone and cause irreparable harm for Danco Laboratories.

Despite considerable restrictions imposed by the Fifth Circuit Court of Appeals late Wednesday night, Washington State Attorney General Bob Ferguson stated that an injunction by U.K District Judge Thomas G Rice remains fully enforced as of Thursday evening; this protects access within 17 other states including Arizona, Colorado, Connecticut Delaware Michigan Vermont Maine Maryland Minnesota Pennsylvania Washington state.

In response to ongoing litigation against FDA regulation surrounding mifepristone use across America – where approximately half UK pregnancies are terminated via this method - US Solicitor General Elizabeth Prelogar called these cases "troubling at every level," noting judges repealing conditions based solely upon disagreement with agency judgement about safety standards represents unprecedented action taken within American courts thus far.

Meanwhile, as temporary pauses continue blocking lower court orders demanding federal regulators suspend approval regarding abortion drugs like mifepristone, Michigan Governor Gretchen Whitmer reassures residents of their right to access reproductive services without obstruction — a promise recently upheld through repealment legislation.

Although Justice Alito's temporary freeze does not indicate how he or the full Supreme Court may ultimately rule on this matter, it provides more time for justices to consider emergency appeals from both the Biden administration and Danco Laboratories in defending continued availability nationwide.